When it comes to biopharmaceutical drug discovery and development, we live in an incredible time. The FDA has approved innovative medicines with differing approaches, platforms, technologies, and modalities. As we leverage new technologies, our strategies for drug discovery are leading to therapeutic diversity, which is rapidly becoming a complicated landscape for manufacturing teams.
In this eBook authored by Amit Bhatia, Anthony Reese, and Akhil Rachamadugu of Scimitar, Inc., learn how diverse therapies are creating complexity and how digital innovations are driving modernization in today’s biopharmaceutical landscape.
Topics covered:
- Novel Technologies and Platforms
- Every Patient is a “Batch”
- What is Needed to Scale for Success?
- Case Studies
